SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
Press Releases
Light-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy
March 2, 2026
 · 
6 min read
Press Releases
Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March
March 2, 2026
 · 
4 min read
Press Releases
Sharp Therapeutics Announces Closing of First Tranche of Unsecured Convertible Note Offering
February 27, 2026
 · 
5 min read
Press Releases
Telo Genomics Corp. Announces Upsizing of Previously Announced Private Placement
February 27, 2026
 · 
5 min read
Press Releases
Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million
February 27, 2026
 · 
6 min read
Press Releases
Restart Life Sciences Closes Acquisition of Holy Crap Foods
February 27, 2026
 · 
8 min read
Press Releases
Ketryx Enters 2026 with Record Momentum as Demand for Validated AI Surges
February 26, 2026
 · 
1 min read
Press Releases
Optimi Health Reports Early Clinical Rollout of Natural Psilocybin Capsules for Treatment-Resistant Depression in Australia
February 26, 2026
 · 
5 min read
Press Releases
TempraMed Reports over 275 Clinicians Recommending VIVI Cap to Patients on Leading FrontrowMD Platform Across the United States
February 26, 2026
 · 
5 min read
Press Releases
PreveCeutical Announces Canadian Patent Office Allowance of Innovative Pain Therapy Technology
February 25, 2026
 · 
6 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us